The Journal of Urology
Volume 181, Issue 1 , Pages 13-14 , January 2009

Diabetic Cystopathy—What Does it Mean?

  • Jeanette S. Brown

      Affiliations

    • Financial interest and/or other relationship with Allergan and Pfizer.

References 

  1. Brown JS, Wessells H, Chancellor MB, Howards SS, Stamm WE, Stapleton AE, et al. Urologic complications of diabetes. Diabetes Care. 2005;28:177
  2. Cowie CC, Rust KF, Byrd-Holt DD, Eberhardt MS, Flegal KM, Engelgau MM, et al. Prevalence of diabetes and impaired fasting glucose in adults in the U.S. population: National Health and Nutrition Examination Survey 1999-2002. Diabetes Care. 2006;29:1263
  3. Brown JS, Vittinghoff E, Lin F, Nyberg LM, Kusek JW, Kanaya AM. Prevalence and risk factors for urinary incontinence in women with type 2 diabetes and impaired fasting glucose: findings from the National Health and Nutrition Examination Survey (NHANES) 2001-2002. Diabetes Care. 2006;29:1307
  4. Varmus H. Disease-Specific Estimates of Direct and Indirect Costs of Illness and NIH Support. Bethesda, Maryland: Department of Health and Human Services, National Institutes of Health, Office of the Director September; 1997;
  5. Wilson L, Brown JS, Shin GP, Luc KO, Subak LL. Annual direct cost of urinary incontinence. Obstet Gynecol. 2001;98:398
  6. Hill SR, Fayyad AM, Jones GR. Diabetes mellitus and female lower urinary tract symptoms: a review. Neurourol Urodyn. 2008;27:362
  7. Lee WC, Wu HP, Tai TY, Liu SP, Chen J, Yu HJ. Effects of diabetes on female voiding behavior. J Urol. 2004;172:989
  8. Lifford KL, Curhan GC, Hu FB, Barbieri RL, Grodstein F. Type 2 diabetes mellitus and risk of developing urinary incontinence. J Am Geriatr Soc. 2005;53:1851
  9. Yoshimura N, Chancellor MB, Andersson KE, Christ GJ. Recent advances in understanding the biology of diabetes-associated bladder complications and novel therapy. BJU Int. 2005;95:733

PII: S0022-5347(08)02804-8

doi: 10.1016/j.juro.2008.10.078

The Journal of Urology
Volume 181, Issue 1 , Pages 13-14 , January 2009